Filter
805
Filtered Results: 805
Text search:
García,
J.M.
Featured
Recommendations
63
New Publications
104
Language
Document type
No document type
314
Studies & Reports
218
Guidelines
155
Manuals
51
Fact sheets
28
Strategic & Response Plan
23
Training Material
12
Situation Updates
2
Resource Platforms
1
Infographics
1
Countries / Regions
Latin America and the Carribbean
53
Brazil
32
Global
30
Colombia
24
Russia
22
Venezuela
15
Western and Central Europe
13
Argentina
13
India
13
Africa
12
Mozambique
11
Paraguay
11
Philippines
10
Ukraine
8
Middle East and North Africa
8
Chile
7
Peru
7
Germany
7
Spain
7
Bolivia
7
Eastern Europe
7
Kenya
5
Syria
5
Senegal
5
South Africa
5
Uganda
5
Yemen
5
Angola
5
Nepal
4
Mexico
4
El Salvador
4
Sierra Leone
4
Guinea-Bissau
4
Tanzania
4
Portugal
4
Ghana
3
USA
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Vietnam
3
Zambia
3
Indonesia
3
North Macedonia
2
Thailand
2
Zimbabwe
2
Guinea
2
Haiti
2
Asia
2
North America
2
France
2
United Kingdom
2
Lebanon
2
Georgia
2
South Sudan
2
Lesotho
1
Turkey
1
China
1
Rwanda
1
Cameroon
1
Nigeria
1
Canada
1
Estonia
1
Kyrgyzstan
1
Burkina Faso
1
Afghanistan
1
Morocco
1
Italy
1
Armenia
1
Cambodia
1
Hungary
1
West and Central Africa
1
Uruguay
1
Jamaica
1
Belgium
1
Norway
1
Belarus
1
Israel
1
Bangladesh
1
Sri Lanka
1
Sudan
1
Romania
1
Ethiopia
1
Liberia
1
Ecuador
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
236
Clinical Guidelines
75
Public Health
45
Women & Child Health
38
Key Resources
13
Capacity Building
5
Pharmacy & Technologies
4
Toolboxes
COVID-19
146
HIV
83
TB
77
Mental Health
74
NTDs
65
Planetary Health
48
NCDs
27
Global Health Education
17
Disability
16
AMR
14
Refugee
13
Caregiver
13
Rapid Response
11
Ebola & Marburg
9
Health Financing Toolbox
8
Pharmacy
7
Zika
6
Conflict
5
Social Ethics
3
Natural Hazards
2
Cholera
1
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d...
Measuring progress towards universal health coverage.
This sixth edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, health care expenditure and financing and quality of care across 27 Asia-...
Brief review of selected topics
The following pages provide a focus on selected areas in relation to neurology. The specialists who contributed the reviews are listed in the Project Team and Partners
Neurology Atlas (2004)
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Taeniasis and cysticercosis caused by the parasite T. solium affect vulnerable populations,
mainly in Latin America, sub-Saharan Africa and Asia, where pigs (the intermediate host) roam
free and poor sanitation allows pigs access to human faeces.
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides a framework to inform the exercise of the new essential functions. The th...
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality of care for critically ill patients, especially in low-staffed and low-resourced settings, and mortal...
Methodology for evaluating national national arboviral disease prevention and and control of arboviral diseases in the Americas
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Esta publicación integra la experiencia acumulada de la OPS y las buenas prácticas desarrolladas por sus Estados Miembros en los últimos años, incluidas las discusiones y experiencias compartidas en las reuniones regionales celebradas sobre el tema, y pone el acento en la innovación y la inclus...
1 marco 2021. As orientações deste documento visam, principalmente, equipar o pessoal da saúde com ferramentas que lhes permitam aumentar a eficiência da comunicação com a população geral e aumentar, manter ou recuperar a confiança do público nas vacinas e nos programa de imunização na R...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
